What is the recommended dosage and treatment protocol for trifluridine (antiviral medication) eye drops for viral infections of the eye?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Trifluridine eye drops are recommended as a 1% solution for viral eye infections, particularly herpes simplex keratitis, with a dosage of 1 drop onto the cornea of the affected eye five to eight times per day, as suggested by the most recent study 1. The treatment protocol for trifluridine eye drops typically involves administering the drops until the corneal ulcer heals, and then reducing the frequency to prevent potential corneal toxicity with prolonged use.

  • Key considerations for trifluridine eye drops include:
    • Dosage: 1% solution, five to eight times per day 1
    • Treatment duration: until the corneal ulcer heals, with a maximum of 21 days to avoid corneal toxicity 1
    • Administration: patients should tilt their head back, pull down the lower eyelid to form a pocket, look up, and place the drop in the pocket without touching the dropper to the eye or surrounding tissues
    • Potential side effects: mild burning or stinging upon application, and patients should be advised to contact their doctor if they experience increased eye pain, redness, irritation, or no improvement after 7 days of treatment
  • It is essential to note that trifluridine inevitably causes epithelial toxicity if used for more than 2 weeks, and topical ganciclovir is less toxic to the ocular surface 1.
  • Patients should have a follow-up visit within 1 week of treatment, consisting of an interval history, visual acuity measurement, and slit-lamp biomicroscopy, as recommended by the most recent study 1.

From the Research

Recommended Dosage and Treatment Protocol

  • The recommended dosage of trifluridine eye drops is 1% solution, with the frequency of administration varying depending on the study 2, 3.
  • In one study, trifluridine 1% solution was effective in over 90% of patients with dendritic ulcers, with a high success rate and minimal side effects reported 2.
  • Another study found that trifluridine administered 5 times a day was as effective as 1% cidofovir, and that treatment with cidofovir was as effective as that with trifluridine 3.

Comparison with Other Antiviral Agents

  • Trifluridine has been compared to other antiviral agents, including idoxuridine, vidarabine, acyclovir, and ganciclovir, with varying results 4, 5, 6.
  • One study found that trifluridine and acyclovir were more effective than idoxuridine or vidarabine, and similar in therapeutic effectiveness 4, 5.
  • Another study found that trifluridine, acyclovir, and vidarabine were more effective than idoxuridine for the treatment of dendritic or geographic epithelial keratitis 6.

Treatment Outcomes

  • The treatment outcomes for trifluridine eye drops have been evaluated in several studies, with varying results 2, 3, 4, 5, 6.
  • One study found that trifluridine treatment was highly effective in a rabbit model, even when given only once a day 3.
  • Another study found that trifluridine and acyclovir were more effective than idoxuridine or vidarabine, with a higher proportion of eyes healed at 14 days 4, 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.